Literature DB >> 6381893

Therapeutic effect of sodium tanshinone IIA sulfonate in patients with coronary heart disease. A double blind study. Shanghai Cooperative Group for the Study of Tanshinone IIA.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6381893

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN： 0255-2922            Impact factor:   0.848


× No keyword cloud information.
  9 in total

1.  Sodium tanshinone IIA sulfonate protects rat myocardium against ischemia-reperfusion injury via activation of PI3K/Akt/FOXO3A/Bim pathway.

Authors:  Mei-qi Zhang; Yue-liang Zheng; Huan Chen; Jian-feng Tu; Ye Shen; Jun-ping Guo; Xiang-hong Yang; Shu-ren Yuan; Liang-zhong Chen; Jing-jie Chai; Jian-hong Lu; Chang-lin Zhai
Journal:  Acta Pharmacol Sin       Date:  2013-09-30       Impact factor: 6.150

2.  Effect of magnesium tanshinoate B on the production of nitric oxide in endothelial cells.

Authors:  K O; F Cheung; F L Sung; D Y Zhu; Y L Siow
Journal:  Mol Cell Biochem       Date:  2000-04       Impact factor: 3.396

3.  Effect of sodium tanshinone II A sulfonate on cardiac myocyte hypertrophy and its underlying mechanism.

Authors:  Jun Feng; Zhi Zheng
Journal:  Chin J Integr Med       Date:  2008-10-14       Impact factor: 1.978

4.  Tanshinone IIA protects H9c2 cells from oxidative stress-induced cell death via microRNA-133 upregulation and Akt activation.

Authors:  Yunfei Gu; Zhuo Liang; Haijun Wang; Jun Jin; Shouyan Zhang; Shufeng Xue; Jianfeng Chen; Huijuan He; Kadan Duan; Jing Wang; Xuewei Chang; Chunguang Qiu
Journal:  Exp Ther Med       Date:  2016-05-26       Impact factor: 2.447

5.  Tanshinones induce tumor cell apoptosis via directly targeting FHIT.

Authors:  Xianglian Zhou; Yuting Pan; Yue Wang; Bojun Wang; Yu Yan; Yi Qu; Xisong Ke
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

6.  Preparation and characterisation of solid dispersions of tanshinone IIA, cryptotanshinone and total tanshinones.

Authors:  Xifeng Zhai; Chunguang Li; George Binh Lenon; Charlie C L Xue; Weize Li
Journal:  Asian J Pharm Sci       Date:  2016-08-31       Impact factor: 6.598

Review 7.  Therapeutic Effect of Tanshinone IIA on Liver Fibrosis and the Possible Mechanism: A Preclinical Meta-Analysis.

Authors:  Qingji Ying; Yangyang Teng; Jing Zhang; Zhenzhai Cai; Zhanxiong Xue
Journal:  Evid Based Complement Alternat Med       Date:  2019-12-13       Impact factor: 2.629

Review 8.  Tanshinones: sources, pharmacokinetics and anti-cancer activities.

Authors:  Yong Zhang; Peixin Jiang; Min Ye; Sung-Hoon Kim; Cheng Jiang; Junxuan Lü
Journal:  Int J Mol Sci       Date:  2012-10-22       Impact factor: 5.923

9.  An NQO1-initiated and p53-independent apoptotic pathway determines the anti-tumor effect of tanshinone IIA against non-small cell lung cancer.

Authors:  Fang Liu; Guo Yu; Guangji Wang; Huiying Liu; Xiaolan Wu; Qiong Wang; Miao Liu; Ke Liao; Mengqiu Wu; Xuefang Cheng; Haiping Hao
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.